Nanox Imaging Faces Nasdaq Delisting Over Low Stock Price

Nanox Imaging received a Nasdaq delisting notice after its stock closed below $1 for 30 consecutive business days. Currently trading around $0.64, the company has 180 days (until March 29, 2027) to achieve a closing bid price ≥$1 for 10 consecutive days to regain compliance.

• The notice follows an estimated Q2 EBITDA loss of $11.3 million and a $41 million impairment charge on intangible assets.
• Nanox also owns teleradiology firm USARad and AI-maker Zebra Medical, acquired in 2021 for over $200 million.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.